Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | REPL |
---|---|---|
09:32 ET | 2650 | 8.43 |
09:34 ET | 4553 | 8.335 |
09:36 ET | 1000 | 8.25 |
09:38 ET | 2417 | 8.225 |
09:39 ET | 2100 | 8.17 |
09:41 ET | 2630 | 8.15 |
09:43 ET | 2269 | 8.155 |
09:45 ET | 1300 | 8.15 |
09:48 ET | 4334 | 8.27 |
09:50 ET | 798 | 8.22 |
09:52 ET | 4853 | 8.185 |
09:54 ET | 1529 | 8.17 |
09:56 ET | 2553 | 8.11 |
09:57 ET | 600 | 8.11 |
09:59 ET | 3459 | 8.145 |
10:01 ET | 3525 | 8.13 |
10:03 ET | 893 | 8.11 |
10:06 ET | 200 | 8.08 |
10:08 ET | 597 | 8.05 |
10:10 ET | 1100 | 8.04 |
10:12 ET | 2866 | 8.06 |
10:14 ET | 3351 | 8.07 |
10:15 ET | 1000 | 8.11 |
10:17 ET | 1396 | 8.12 |
10:19 ET | 300 | 8.13 |
10:21 ET | 500 | 8.1225 |
10:24 ET | 2162 | 8.16 |
10:28 ET | 4428 | 8.21 |
10:30 ET | 1000 | 8.225 |
10:32 ET | 492 | 8.235 |
10:33 ET | 825 | 8.23 |
10:35 ET | 1900 | 8.26 |
10:37 ET | 400 | 8.24 |
10:39 ET | 100 | 8.24 |
10:42 ET | 900 | 8.25 |
10:44 ET | 2300 | 8.28 |
10:46 ET | 2796 | 8.3 |
10:48 ET | 3282 | 8.29 |
10:50 ET | 1669 | 8.3 |
10:51 ET | 900 | 8.32 |
10:53 ET | 100 | 8.34 |
10:55 ET | 400 | 8.32 |
10:57 ET | 100 | 8.32 |
11:00 ET | 300 | 8.32 |
11:02 ET | 5552 | 8.354 |
11:04 ET | 3459 | 8.37 |
11:08 ET | 4306 | 8.36 |
11:09 ET | 1300 | 8.3475 |
11:11 ET | 500 | 8.3525 |
11:13 ET | 2041 | 8.36 |
11:15 ET | 2148 | 8.4 |
11:18 ET | 1827 | 8.4 |
11:20 ET | 5604 | 8.37 |
11:22 ET | 100 | 8.375 |
11:24 ET | 3255 | 8.39 |
11:26 ET | 400 | 8.37 |
11:27 ET | 1477 | 8.38 |
11:29 ET | 100 | 8.375 |
11:31 ET | 2155 | 8.36 |
11:33 ET | 400 | 8.35 |
11:36 ET | 200 | 8.34 |
11:38 ET | 1114 | 8.34 |
11:40 ET | 2274 | 8.38 |
11:44 ET | 100 | 8.37 |
11:45 ET | 317 | 8.38 |
11:47 ET | 1241 | 8.36 |
11:49 ET | 1543 | 8.36 |
11:51 ET | 750 | 8.37 |
11:54 ET | 1535 | 8.3703 |
11:56 ET | 531 | 8.36 |
11:58 ET | 1500 | 8.375 |
12:00 ET | 4319 | 8.34 |
12:02 ET | 2521 | 8.35 |
12:03 ET | 1042 | 8.34 |
12:05 ET | 6038 | 8.38 |
12:07 ET | 1705 | 8.34 |
12:09 ET | 3900 | 8.345 |
12:12 ET | 2706 | 8.31 |
12:14 ET | 4284 | 8.32 |
12:16 ET | 3734 | 8.29 |
12:18 ET | 1629 | 8.3 |
12:20 ET | 200 | 8.29 |
12:21 ET | 1496 | 8.28 |
12:23 ET | 2481 | 8.29 |
12:25 ET | 3404 | 8.309 |
12:27 ET | 1124 | 8.32 |
12:30 ET | 1534 | 8.31 |
12:32 ET | 1844 | 8.3 |
12:34 ET | 2000 | 8.31 |
12:36 ET | 3403 | 8.29 |
12:39 ET | 4320 | 8.285 |
12:41 ET | 1000 | 8.28 |
12:43 ET | 1108 | 8.275 |
12:45 ET | 1792 | 8.285 |
12:48 ET | 837 | 8.29 |
12:50 ET | 300 | 8.29 |
12:52 ET | 7511 | 8.23 |
12:54 ET | 22281 | 8.17 |
12:56 ET | 7304 | 8.2 |
12:57 ET | 4900 | 8.21 |
12:59 ET | 20736 | 8.21 |
01:01 ET | 2400 | 8.215 |
01:03 ET | 3100 | 8.22 |
01:06 ET | 1800 | 8.24 |
01:08 ET | 1300 | 8.24 |
01:10 ET | 726 | 8.245 |
01:12 ET | 2439 | 8.25 |
01:14 ET | 1759 | 8.26 |
01:15 ET | 2105 | 8.25 |
01:17 ET | 100 | 8.24 |
01:19 ET | 1400 | 8.26 |
01:21 ET | 1291 | 8.265 |
01:26 ET | 1238 | 8.25 |
01:28 ET | 13911 | 8.26 |
01:30 ET | 45113 | 8.26 |
01:32 ET | 3764 | 8.25 |
01:33 ET | 47702 | 8.255 |
01:35 ET | 17313 | 8.265 |
01:37 ET | 200 | 8.27 |
01:39 ET | 6138 | 8.32 |
01:42 ET | 800 | 8.325 |
01:44 ET | 3109 | 8.31 |
01:46 ET | 4904 | 8.28 |
01:48 ET | 2601 | 8.27 |
01:50 ET | 4809 | 8.29 |
01:51 ET | 500 | 8.28 |
01:53 ET | 300 | 8.28 |
01:55 ET | 2800 | 8.29 |
01:57 ET | 130 | 8.295 |
02:00 ET | 1956 | 8.31 |
02:02 ET | 950 | 8.32 |
02:06 ET | 1864 | 8.315 |
02:08 ET | 1584 | 8.34 |
02:09 ET | 1365 | 8.37 |
02:11 ET | 200 | 8.38 |
02:13 ET | 100 | 8.375 |
02:15 ET | 644 | 8.365 |
02:18 ET | 1300 | 8.38 |
02:20 ET | 855 | 8.37 |
02:22 ET | 881 | 8.39 |
02:24 ET | 511 | 8.379 |
02:26 ET | 2191 | 8.42 |
02:27 ET | 804 | 8.41 |
02:29 ET | 4663 | 8.43 |
02:31 ET | 9383 | 8.4 |
02:33 ET | 400 | 8.38 |
02:36 ET | 220 | 8.3803 |
02:38 ET | 3557 | 8.36 |
02:40 ET | 100 | 8.36 |
02:42 ET | 1573 | 8.37 |
02:44 ET | 1699 | 8.37 |
02:45 ET | 870 | 8.365 |
02:47 ET | 2410 | 8.385 |
02:49 ET | 2800 | 8.38 |
02:51 ET | 700 | 8.37 |
02:54 ET | 300 | 8.35 |
02:56 ET | 2507 | 8.36 |
02:58 ET | 1900 | 8.36 |
03:00 ET | 2440 | 8.355 |
03:03 ET | 2900 | 8.34 |
03:05 ET | 2000 | 8.33 |
03:07 ET | 1489 | 8.33 |
03:09 ET | 1052 | 8.34 |
03:12 ET | 2200 | 8.34 |
03:14 ET | 1133 | 8.34 |
03:16 ET | 5973 | 8.355 |
03:18 ET | 9969 | 8.34 |
03:20 ET | 100 | 8.335 |
03:21 ET | 6341 | 8.335 |
03:23 ET | 1900 | 8.325 |
03:30 ET | 6570 | 8.3254 |
03:32 ET | 16170 | 8.33 |
03:34 ET | 700 | 8.325 |
03:36 ET | 2644 | 8.32 |
03:38 ET | 800 | 8.32 |
03:39 ET | 1300 | 8.315 |
03:41 ET | 519 | 8.315 |
03:43 ET | 300 | 8.31 |
03:45 ET | 4971 | 8.315 |
03:48 ET | 2668 | 8.295 |
03:50 ET | 3072 | 8.25 |
03:52 ET | 10863 | 8.21 |
03:54 ET | 11160 | 8.23 |
03:56 ET | 13542 | 8.19 |
03:57 ET | 9280 | 8.175 |
03:59 ET | 63889 | 8.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Replimune Group Inc | 506.4M | -2.6x | --- |
Lexeo Therapeutics Inc | 503.1M | -5.8x | --- |
Lyell Immunopharma Inc | 518.4M | -2.4x | --- |
Oculis Holding AG | 436.5M | 0.0x | --- |
Mereo BioPharma Group PLC | 420.7M | -12.5x | --- |
Altimmune Inc | 477.6M | -6.5x | --- |
Replimune Group, Inc. is a clinical-stage biotechnology company engaged in the business of oncolytic immunotherapy to treat cancer patients. The Company is advancing a pipeline of tumor-directed oncolytic immunotherapies derived from its RPx platform to fill unmet need across cancer types. The Company's lead product candidate, RP1, is a selectively replicating version of HSV-1 that expresses GALV-GP R and human GM-CSF. RP1 is designed to treat more immune responsive tumor types. The Company's pipeline product candidates include RP2 and RP3. The encoded GALV-GP R protein enhances the tumor killing ability of the virus and increases immunogenic cell death. RP2 is an additionally encodes an anti-CTLA-4 antibody has designed to treat more immunologically silent tumors. RP3 expresses a pair of immune costimulatory pathways activating ligands, CD40L and 4-1BBL, to further increase the potency of the immune responses to treat immunologically cold tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $506.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 61.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-3.16 |
Book Value | $9.80 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.